Frontage Holdings Corporation, commonly referred to as Frontage, is a leading global contract research organisation headquartered in the United States. Established in 2001, the company has made significant strides in the pharmaceutical and biotechnology sectors, providing comprehensive drug development services. With operational hubs across North America, Europe, and Asia, Frontage is well-positioned to support clients worldwide. Specialising in preclinical and clinical research, Frontage offers a unique blend of laboratory services, including bioanalytical testing, formulation development, and regulatory support. Their commitment to innovation and quality has earned them a strong market position, recognised for their expertise in accelerating drug development timelines. With a focus on client collaboration and scientific excellence, Frontage continues to achieve notable milestones in advancing healthcare solutions.
How does Frontage Holdings's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Frontage Holdings's score of 29 is higher than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Frontage Holdings reported total carbon emissions of approximately 18,185,280 kg CO2e, comprising 2,883,150 kg CO2e from Scope 1 and 15,302,130 kg CO2e from Scope 2 emissions. This reflects a slight decrease from 2022, where total emissions were about 18,759,240 kg CO2e, with Scope 1 at 2,816,760 kg CO2e and Scope 2 at 15,942,480 kg CO2e. Over the past few years, emissions have shown a general trend of fluctuation, with 2021 emissions recorded at approximately 11,941,580 kg CO2e, indicating a need for ongoing monitoring and improvement. Frontage Holdings does not currently disclose any Scope 3 emissions data, which typically includes indirect emissions from the supply chain and product use. The company has not set specific reduction targets or climate pledges, as indicated by the absence of documented reduction initiatives or SBTi targets. As a current subsidiary of Frontage Holdings Corporation, emissions data and performance metrics are cascaded from the parent company. The company is committed to transparency in its environmental impact, as evidenced by its annual reporting. However, without specific reduction commitments, the focus remains on managing and reporting existing emissions levels.
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Scope 1 | 866,070 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 5,187,190 | 0,000,000 | 0,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Frontage Holdings has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.